<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03326635</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL17_0017</org_study_id>
    <nct_id>NCT03326635</nct_id>
  </id_info>
  <brief_title>Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.</brief_title>
  <acronym>FRAGIREA</acronym>
  <official_title>Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study design. The study FRAGIREA is a multicentric prevalence study on the frequency of
      frailty among elderly patients and the quality of management. The voluntary ICUs will have to
      include all patients ≥ 70 years on a limited period (1 month) or until the number of 15
      inclusions is reached. The frailty is going to be evaluated by a frailty score adapted to the
      ICU, based on informations given by the patient's family.

      It is a descriptive non-interventional study, aiming at the description of frequency of
      frailty and management of the patient in order to set-up a prospective future study on the
      potential role of early rehabilitation of ageing patients in ICUs.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 2018</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frailty in elderly (≥70 years old) patients in intensive care unit (ICU)</measure>
    <time_frame>One month or 15 patients ≥ 70 years old</time_frame>
    <description>We assessed the 5 components of Fried's frailty index, resulting from cumulative decline across multiple physiological systems and contain five criteria (shrinking, weakness, slowness, low-level physical activity, and self-reported exhaustion). All five components were considered from the previously reported definition and adapted to the ICU environment. The patients were considered to be frail if they had three or more frailty components among the five criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Organ failures</measure>
    <time_frame>About 8 days</time_frame>
    <description>During the patients' hospitalization in ICU, the following data were collected last day in ICU:
the need for dialysis during ICU the duration of mechanical ventilation (number of days under mechanical ventilation) the duration of shock (number of days under catecholamines)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional support</measure>
    <time_frame>About 8 days</time_frame>
    <description>Nutritional intake during ICU stay, from the first day to the patient's exit, including route of administration (enteral, parenteral), last day in ICU we assessed:
number of days under enteral nutrition number of days under enteral parenteral nutrition calculation of the average calorie / day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehabilitation</measure>
    <time_frame>About 8 days</time_frame>
    <description>Last day in ICU, we record the highest level of mobilization achieved during the ICU period, the following ordinal scale was used: 1) no mobilization, 2) turning in bed, 3) sitting in bed with the head of bed elevated, 4) sitting on the edge of the bed with feet on floor, 5) sitting out of bed in a chair, 6) standing out of bed, 7) marching in place, 8) walking, 9) using cycloergometer and 9) using electrical muscle stimulation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>90 days</time_frame>
    <description>ICU mortality and Hospital mortality Decision of therapeutics limitation. Length of stay (ICU and hospital stay).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Resuscitation</condition>
  <arm_group>
    <arm_group_label>frailty group</arm_group_label>
    <description>frailty score ≤ 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-frailty group</arm_group_label>
    <description>frailty score &gt;3</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Frailty in elderly (≥70 y) patients in ICU</intervention_name>
    <description>Determine the prevalence of frailty in elderly patients (≥ 70 year old) in a group of French ICUs. The frailty is measured by a score (Fried score) at the admission of the patient</description>
    <arm_group_label>frailty group</arm_group_label>
    <arm_group_label>non-frailty group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients ≥ 70 year-old admitted to an ICU.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥ 70 year-old

          -  Prevision of a length of stay &gt; 24 hrs.

          -  Patient or relative who received information about the study and did not oppose it

        Exclusion Criteria:

          -  Life expectancy &lt; 24 hrs

          -  Patients unable to communicate and no next of kin available.

          -  adults, non-emancipated minors, persons unable to receive information,

          -  persons placed under the safeguard of justice,

          -  subject participating in another search including an exclusion period still in
             progress at pre-inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CH Aix en Provence</name>
      <address>
        <city>Aix-en-Provence</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier BALDESI, MD</last_name>
      <email>obaldesi@ch-aix.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier BALDESI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sigismond LASOCKI, MD</last_name>
      <email>silasocki@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Sigismond LASOCKI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Annecy</name>
      <address>
        <city>Annecy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Albrice LEVRAT, MD</last_name>
      <email>alevrat@ch-annecygenevois.fr</email>
    </contact>
    <investigator>
      <last_name>Albrice LEVRAT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Annonay</name>
      <address>
        <city>Annonay</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent CADIERGUE, MD</last_name>
      <email>vcadiergue@ch-annonay.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent CADIERGUE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Argentueil</name>
      <address>
        <city>Argenteuil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gaëtan PLANTEFEVE, MD</last_name>
      <email>gaetan.plantefeve@ch-argenteuil.fr</email>
    </contact>
    <investigator>
      <last_name>Gaëtan PLANTEFEVE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Belfort</name>
      <address>
        <city>Belfort</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julio BADIE, MD</last_name>
      <email>julio.badie@hnfc.fr</email>
    </contact>
    <investigator>
      <last_name>Julio BADIE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Bourg en Bresse</name>
      <address>
        <city>Bourg-en-Bresse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rémi BRUYERE, MD</last_name>
      <email>rbruyere@ch-bourg01.fr</email>
    </contact>
    <investigator>
      <last_name>Rémi BRUYERE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Bourgoin-Jallieu</name>
      <address>
        <city>Bourgoin-Jallieu</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stanislas LEDOCHOWSKI, MD</last_name>
      <email>s.ledochowski@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Stanislas LEDOCHOWSKI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Béziers</name>
      <address>
        <city>Béziers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurent FAVIER, MD</last_name>
      <email>laurent.favier@ch-beziers.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent FAVIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Chalons sur Saône</name>
      <address>
        <city>Chalon-sur-Saône</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Marc DOISE, MD</last_name>
      <email>jean-marc.doise@ch-chalon71.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Marc DOISE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Chambéry</name>
      <address>
        <city>Chambéry</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bénédicte ZERR, MD</last_name>
      <email>zerr.benedicte@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Bénédicte ZERR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand SOUWEINE, MD</last_name>
      <email>bsouweine@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Bertrand SOUWEINE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Michel CONSTANTIN, MD</last_name>
      <email>jmconstantin@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Michel CONSTANTIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble</name>
      <address>
        <city>La Tronche</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carole SCHWEBEL, MD</last_name>
      <email>cschwebel@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Carole SCHWEBEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Edouard Herriot, G Réa</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bernard FLOCCARD, MD</last_name>
      <email>bernard.floccard@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Bernard FLOCCARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Edouard Herriot, N réa</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurent ARGAUD, MD</last_name>
      <email>laurent.argaud@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent ARGAUD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Edouard Herriot, P Réa</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas RIMMELE, MD</last_name>
      <email>thomas.rimmele@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Thomas RIMMELE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Céline GUICHIN, MD</last_name>
      <email>celine.guichon@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Céline GUICHIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HM Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marc LEONE, MD</last_name>
      <email>marc.leone@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Marc LEONE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HM La Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marc GAINNIER, MD</last_name>
      <email>marc.gainnier@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Marc GAINNIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Montauban</name>
      <address>
        <city>Montauban</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michel BONNIVARD, MD</last_name>
      <email>m.bonnivard@ch-montauban.fr</email>
    </contact>
    <investigator>
      <last_name>Michel BONNIVARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Montélimar</name>
      <address>
        <city>Montélimar</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier MILLET, MD</last_name>
      <email>olivier.millet@ch-montelimar.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier MILLET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Moulins</name>
      <address>
        <city>Moulins</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luc JARRIGE, MD</last_name>
      <email>l.jarrige@ch-moulins-yzeure.fr</email>
    </contact>
    <investigator>
      <last_name>Luc JARRIGE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean REIGNIER, MD</last_name>
      <email>jean.reignier@univ-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Jean REIGNIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre-Eric DANIN, MD</last_name>
      <email>danin.pe@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre-Eric DANIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Claude ORBAN, MD</last_name>
      <email>orban.jc@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Claude ORBAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean DELLAMONICA, MD</last_name>
      <email>dellamonica.j@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Jean DELLAMONICA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud Réa Nord</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie DARIEN, MD</last_name>
      <email>marie.darien@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Marie DARIEN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice THIOLLIERE, MD</last_name>
      <phone>04 78 86 56 03</phone>
      <phone_ext>+33</phone_ext>
      <email>fabrice.thiolliere01@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alain LEPAPE, MD</last_name>
      <phone>04 78 86 19 89</phone>
      <phone_ext>+33</phone_ext>
      <email>alain.lepape@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Fabrice THIOLLIERE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alain LEPAPE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnaud FRIGGERI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mélanie LEVRARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard ALLAOUCHICHE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claire DAHYOT-FIZELIER, MD</last_name>
      <email>claire.dahyot-fizelier@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Claire DAHYOT-FIZELIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adel MAAMAR, MD</last_name>
      <email>adel.maamar@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Adel MAAMAR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe SEGUIN, MD</last_name>
      <email>philippe.seguin@chu-renne.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe SEGUIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benoît VEBER, MD</last_name>
      <email>benoit.veber@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Benoît VEBER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benoît MISSET, MD</last_name>
      <email>benoit.misset@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Benoît MISSET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Saint Denis</name>
      <address>
        <city>Saint-Denis</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gabriel PREDA, MD</last_name>
      <email>gabropreda@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gabriel PREDA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital Nord</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jérôme MOREL, MD</last_name>
      <email>jerome.morel@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Jérôme MOREL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Salons de Provence</name>
      <address>
        <city>Salon-de-Provence</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ali MOFREDJ, MD</last_name>
      <email>ali.mofredj@ch-salon.fr</email>
    </contact>
    <investigator>
      <last_name>Ali MOFREDJ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Valence</name>
      <address>
        <city>Valence</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Quentin BLANC, MD</last_name>
      <email>qblanc@ch-valence.fr</email>
    </contact>
    <investigator>
      <last_name>Quentin BLANC, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Vichy</name>
      <address>
        <city>Vichy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ramin RAVAN, MD</last_name>
      <email>ramin.ravan@ch-vichy.fr</email>
    </contact>
    <investigator>
      <last_name>Ramin RAVAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Sud Francilien</name>
      <address>
        <city>Évry</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gérald CHOUKROUN, MD</last_name>
      <email>gerald.choukroun@ch-sud-francilien.fr</email>
    </contact>
    <investigator>
      <last_name>Gérald CHOUKROUN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Mayotte</name>
      <address>
        <city>Mayotte</city>
        <country>Mayotte</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oriane FONTAINE, MD</last_name>
      <email>o.fontaine@chmayotte.fr</email>
    </contact>
    <investigator>
      <last_name>Oriane FONTAINE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Mayotte</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2017</study_first_submitted>
  <study_first_submitted_qc>October 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>February 2, 2018</last_update_submitted>
  <last_update_submitted_qc>February 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Resuscitation</keyword>
  <keyword>Frailty</keyword>
  <keyword>ICU</keyword>
  <keyword>Ageing</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Elderly</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

